BeOne Medicines (ONC) Amortization - Intangibles (2017 - 2023)
BeOne Medicines (ONC) reported Amortization - Intangibles of -$782000.0 for Q4 2023, up 65.34% year-over-year from -$472973.7 in Q4 2022, and down 160.76% on a QoQ basis from $1.3 million in Q3 2023.
BeOne Medicines (ONC) has 7 years of Amortization - Intangibles data on file, last reported at -$782000.0 in Q4 2023.
- Quarterly Amortization - Intangibles rose 65.34% year-over-year to -$782000.0 in Q4 2023, while the trailing twelve-month figure through Jun 2024 was $505000.0 (up 1018.18% YoY) and the FY2023 annual result came in at $3.5 million, up 366.05% from the prior year.
- Amortization - Intangibles retreated to -$782000.0 in Q4 2023 per ONC's latest filing, from $1.3 million in the prior quarter.
- Across five years, Amortization - Intangibles topped out at $1.3 million in Q3 2023 and bottomed at -$2.3 million in Q4 2022.
- The 5-year median for Amortization - Intangibles is $235500.0 (2020), against an average of $204050.0.
- The widest annual swing landed in 2022, when Amortization - Intangibles sank 1306.42%; it then surged 588.24% in 2023.
- Tracing ONC's Amortization - Intangibles over 5 years: stood at $332000.0 in 2019, then slumped by 43.37% to $188000.0 in 2020, then fell by 0.53% to $187000.0 in 2021, then slumped by 1306.42% to -$2.3 million in 2022, then surged by 65.34% to -$782000.0 in 2023.
- Per Business Quant, the three latest ONC Amortization - Intangibles figures stand at -$782000.0 (Q4 2023), $1.3 million (Q3 2023), and $1.0 million (Q2 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | BeOne Medicines | - | - | 1.35 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -782,000.00 |
| Sep 30, 2023 | 1.29 Mn |
| Jun 30, 2023 | 1.03 Mn |
| Mar 31, 2023 | 986,000.00 |
| Dec 31, 2022 | -2.26 Mn |
| Sep 30, 2022 | 187,000.00 |
| Jun 30, 2022 | 188,000.00 |
| Mar 31, 2022 | 188,000.00 |
| Dec 31, 2021 | 187,000.00 |
| Sep 30, 2021 | 404,000.00 |
| Jun 30, 2021 | 304,000.00 |
| Mar 31, 2021 | 188,000.00 |
| Dec 31, 2020 | 188,000.00 |
| Sep 30, 2020 | 187,000.00 |
| Jun 30, 2020 | 188,000.00 |
| Mar 31, 2020 | 283,000.00 |
| Dec 31, 2019 | 332,000.00 |
| Sep 30, 2019 | 331,000.00 |
| Jun 30, 2019 | 332,000.00 |
| Mar 31, 2019 | 331,000.00 |
| Dec 31, 2018 | 331,000.00 |
| Sep 30, 2018 | 188,000.00 |
| Jun 30, 2018 | 187,000.00 |
| Mar 31, 2018 | 188,000.00 |
| Dec 31, 2017 | 187,000.00 |
| Sep 30, 2017 | 63,000.00 |